This site is only for use by healthcare professionals. By continuing to view this site you are confirming that you are a healthcare professional.
The following is an overview of a satellite symposium held on 29 April 2014 during the BSH Annual Scientific Meeting in Birmingham. The symposium was organised and funded by CTI Life Sciences and...
It is currently an exciting time for those interested in the management of perioperative bleeding; recent advances in understanding and approach herald improvements in the approach to perioperative...
The clinical management of trauma-related bleeding is rapidly evolving. While mechanical bleeding can be addressed through surgical measures, the patient’s coagulopathic state should also be...
Addressing the current challenges involved in the treatment of acute and life-threatening bleeding is key for improving patient outcomes. The timing and nature of the haemostatic interventions are...
In humans, uric acid is the final step in the catabolic pathway of purines. The acute increase in plasma levels of uric acid subsequent to the lysis of large numbers of malignant cells during...
Laura Green1 and Hannah Cohen2 1Department of Haematology, Barts and the London Hospital NHS Trust & NHS Blood & Transplant, London, UK; 2Department of Haematology, University College London...
Surgery for elective total hip (THR) and knee (TKR) replacement is associated with a very high risk of venous thrombosis Some orthopaedic surgeons have been overcautious in their use of prophylaxis,...
Emili Montserrat University of Barcelona, Barcelona, Spain With 17% of people living in the EU now aged 65 years or older, it is becoming increasingly important that we consider whether recommended...
Multiple myeloma is characterised by a number of factors that are typically associated with a poor outcome to conventional treatments, such as advanced age, the presence of renal impairment and...
Welcome to Haematology News, our latest addition to the British Journal of Haematology. This is the second of two issues devoted to chronic lymphocytic leukaemia (CLL) and explores important views...